Literature DB >> 10984457

Identifying potential tumor markers and antigens by database mining and rapid expression screening.

W T Loging1, A Lal, I M Siu, T L Loney, C J Wikstrand, M A Marra, C Prange, D D Bigner, R L Strausberg, G J Riggins.   

Abstract

Genes expressed specifically in malignant tissue may have potential as therapeutic targets but have been difficult to locate for most cancers. The information hidden within certain public databases can reveal RNA transcripts specifically expressed in transformed tissue. To be useful, database information must be verified and a more complete pattern of tissue expression must be demonstrated. We tested database mining plus rapid screening by fluorescent-PCR expression comparison (F-PEC) as an approach to locate candidate brain tumor antigens. Cancer Genome Anatomy Project (CGAP) data was mined for genes highly expressed in glioblastoma multiforme. From 13 mined genes, seven showed potential as possible tumor markers or antigens as determined by further expression profiling. Now that large-scale expression information is readily available for many of the commonly occurring cancers, other candidate tumor markers or antigens could be located and evaluated with this approach.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984457      PMCID: PMC310902          DOI: 10.1101/gr.138000

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  46 in total

1.  Hybridization fingerprinting of high-density cDNA-library arrays with cDNA pools derived from whole tissues.

Authors:  T M Gress; J D Hoheisel; G G Lennon; G Zehetner; H Lehrach
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.

Authors:  B P Wallner; R J Mattaliano; C Hession; R L Cate; R Tizard; L K Sinclair; C Foeller; E P Chow; J L Browing; K L Ramachandran
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

Review 3.  Primary and secondary glioblastomas: from concept to clinical diagnosis.

Authors:  P Kleihues; H Ohgaki
Journal:  Neuro Oncol       Date:  1999-01       Impact factor: 12.300

4.  MRP3, an organic anion transporter able to transport anti-cancer drugs.

Authors:  M Kool; M van der Linden; M de Haas; G L Scheffer; J M de Vree; A J Smith; G Jansen; G J Peters; N Ponne; R J Scheper; R P Elferink; F Baas; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 5.  The biology of SPARC, a protein that modulates cell-matrix interactions.

Authors:  T F Lane; E H Sage
Journal:  FASEB J       Date:  1994-02       Impact factor: 5.191

6.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.

Authors:  D Sidransky; T Tokino; S R Hamilton; K W Kinzler; B Levin; P Frost; B Vogelstein
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

7.  Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents.

Authors:  H Zeng; L J Bain; M G Belinsky; G D Kruh
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

8.  Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library.

Authors:  M D Adams; M B Soares; A R Kerlavage; C Fields; J C Venter
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

9.  Study of natural lipocortin I. A potent mediator for macrophage-mediated immunosuppression in tumor-bearing mice.

Authors:  T Sakata; S Iwagami; Y Tsuruta; S Suzuki; R Suzuki
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

10.  Molecular cloning of cDNAs encoding the human bombesin-like peptide neuromedin B. Chromosomal localization and comparison to cDNAs encoding its amphibian homolog ranatensin.

Authors:  I M Krane; S L Naylor; D Helin-Davis; W W Chin; E R Spindel
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

View more
  23 in total

1.  NMR assignment of a human cancer-related nucleoside triphosphatase.

Authors:  W J Placzek; M A Almeida; K Wüthrich
Journal:  J Biomol NMR       Date:  2006-08-24       Impact factor: 2.835

Review 2.  Chaperone proteins and brain tumors: potential targets and possible therapeutics.

Authors:  Michael W Graner; Darell D Bigner
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

3.  Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.

Authors:  Chien-Tsun Kuan; Kenji Wakiya; Stephen T Keir; Jianjun Li; James E Herndon; Ira Pastan; Darell D Bigner
Journal:  Int J Cancer       Date:  2010-11-03       Impact factor: 7.396

4.  Identification of HTA as a novel-specific marker for human hepatocellular carcinoma.

Authors:  Yan Liu; Yuehui Li; Fengjie Guo; Miao Dai; Jiajia Wang; Jinyue Hu; Guancheng Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-04       Impact factor: 4.553

5.  MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

Authors:  Chien-Tsun Kuan; Kenji Wakiya; James E Herndon; Eric S Lipp; Charles N Pegram; Gregory J Riggins; Ahmed Rasheed; Scott E Szafranski; Roger E McLendon; Carol J Wikstrand; Darell D Bigner
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

6.  Identification of candidate cancer genes involved in human retinoblastoma by data mining.

Authors:  Juhua Yang; Jian-Jun Zhao; Yihua Zhu; Wei Xiong; Jian-Yin Lin; Xu Ma
Journal:  Childs Nerv Syst       Date:  2008-03-19       Impact factor: 1.475

7.  Coexpression of neuronatin splice forms promotes medulloblastoma growth.

Authors:  I-Mei Siu; Renyuan Bai; Gary L Gallia; Jennifer B Edwards; Betty M Tyler; Charles G Eberhart; Gregory J Riggins
Journal:  Neuro Oncol       Date:  2008-08-13       Impact factor: 12.300

8.  Intrathecal siRNA against GPNMB attenuates nociception in a rat model of neuropathic pain.

Authors:  Lili Hou; Yanfeng Zhang; Yong Yang; Kai Xiang; Qindong Tan; Qulian Guo
Journal:  J Mol Neurosci       Date:  2014-07-17       Impact factor: 3.444

9.  Targeted induction of apoptosis in glioblastoma multiforme cells by an MRP3-specific TRAIL fusion protein in vitro.

Authors:  Liang-Hua Wang; Chang-Wei Ni; Yong-Zhong Lin; Lin Yin; Chang-Bin Jiang; Cui-Ting Lv; Yuan Le; Yue Lang; Chen-Yang Zhao; Kang Yang; Bing-Hua Jiao; Jian Yin
Journal:  Tumour Biol       Date:  2013-11-26

10.  Glycoprotein non-metastatic melanoma B expression after hepatic ischemia reperfusion and the effect of silibinin.

Authors:  Adamantios Michalinos; Alexandra K Tsaroucha; Maria Lambropoulou; Dimitrios Schizas; Georgia Valsami; Nikolaos Kostomitsopoulos; Michael S Pitiakoudis; Constantinos E Simopoulos
Journal:  Transl Gastroenterol Hepatol       Date:  2020-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.